Product: DDX5001P-50Anti-Remicade (Infliximab) antibody
Quantity: 50 µg
Synonyms:
Presentation: Purified
Clonality: Monoclonal
Host: Mouse
Isotype: IgG1
CAS NO: 196808-24-9 Product: GW1929
Shipping to: Germany, USA/Canada
Immunogen: Remicade® (Janssen Biologics B.V.) (Infliximab)
Application: DDX5001P-50 DDX5001P-100 Purified: Bridging ELISA positive control for anti-Remicade detection, Inhibition of Remicade binding to TNF-α, Capture antibody for Remicade detection. DDX5001B-50 DDX5001B-100 Biotin: Detection antibody for Remicade detection.Us
Background: Remicade® (Infliximab) is a chimeric monoclonal antibody targeting TNF-α, used for the treatment of autoimmune diseases such as rheumatoid arthritis, ankylosis spondylitis, Crohns disease, psoriatic arthritis or ulcerative colitis. We have generated a pa
Concentration: 0.5 mg/ml
Storage: -20°C. KEEP CONTENTS STERILE: no preservative.Purified antibodies: avoid repeated freeze/thaw cycles.Coupled antibodies: glycerol protects from freezing.
Buffer System: Purified: 100 μg in 200 μl / 50 μg in 100 μl Tris-NaCl pH 8.Coupled: 100 μg in 200 μl / 50 μg in 100 μl PBS 50% glycerol.
Preservatives:
State: Purified
Specifictiy: Remicade® (Infliximab). Cross-reactivity: negative for rituximab (mabthera) and roactemra (tocilizumab).
